Catalyst Pharmaceuticals
CPRX
₹2,153
Share price
-2.22%
Change (1 day)
63.87%
Change (1 year)
Categories
Revenue for Catalyst Pharmaceuticals (CPRX)
Revenue in 2024 (TTM): ₹41.38 Billion
According to Catalyst Pharmaceuticals's latest financial reports the company's current revenue (TTM 
) is ₹42.09 Billion. an increase over the revenue in the year 2023 that were of ₹33.15 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Catalyst Pharmaceuticals from 2009 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | ₹42.18 B | 27.25% |
| 2023 | ₹33.15 B | 87.02% |
| 2022 | ₹17.72 B | 69.1% |
| 2021 | ₹10.48 B | 20.37% |
| 2020 | ₹8.70 B | 19.36% |
| 2019 | ₹7.29 B | 20767.58% |
| 2018 | ₹34.96 M | |
| 2017 | N/A | |
| 2016 | N/A | |
| 2015 | N/A | |
| 2014 | N/A | |
| 2013 | N/A | |
| 2012 | N/A | |
| 2011 | N/A | -100% |
| 2010 | ₹21.91 M | |
| 2009 | N/A |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | ₹244.30 B | 480.38% | 🇺🇸 USA |
 | ₹162.81 B | 286.79% | 🇺🇸 USA |
 | ₹7.603 T | 17,962.81% | 🇺🇸 USA |
 | ₹9.90 B | -76.48% | 🇺🇸 USA |
 | ₹5.446 T | 12,839.11% | 🇺🇸 USA |
 | ₹3.591 T | 8,431.04% | 🇺🇸 USA |